Purification of Baculovirus-Expressed Human DNA Topoisomerase I

  • Lance Stewart
  • James J. Champoux
Part of the Methods in Molecular Biology™ book series (MIMB, volume 94)


DNA topoisomerase I (topo I) can be isolated from cultured human cells in quantities that are more than sufficient for investigations into the ability of topo I to relax supercoiled DNA (250 μg/109 cells) (1,2). However, the production of human topo I (htopo I) in this manner becomes both costly and laborintensive if milligram quantities are needed for structural studies. Although active htopo I has been overexpressed in mammalian cells (3), yeast (4), and Escherichia coli (5,6), these systems have not proven capable of providing large quantities of the protein. In E. coli, the htopo I gene was found to be highly toxic to most strains (3) and appears to contain cryptic prokaryotic promoter elements that lead to constitutive expression of truncated forms of the protein (Madden and Champoux, unpublished observations). In addition, the E. coli-expressed htopo I is very unstable, with proteolytic breakdown products nearly as abundant as those of the full-length protein (6). This is true for htopo I constructs fused to either the T7 gene 10 translation initiation signal (6) or to glutathione-S-transferase (GST). Furthermore, expression in protease-deficient strains of E. coli does not appreciably reduce the proteolytic breakdown of htopo I (unpublished observations).


Potassium Phosphate Buffer Potassium Phosphate Virus Stock Spinner Flask Recombinant Baculoviruses 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Liu, L. F. and Miller, K. G. (1981) Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei. Proc. Natl. Acad. Sci. USA 78, 3487–3491.PubMedCrossRefGoogle Scholar
  2. 2.
    Stewart, L., Ireton, G. C., Parker, L. H., Madden, K. R., and Champoux, J. J. (1996) Biochemical and biophysical analyses of recombinant forms of human topoisomerase I. J. Biol. Chem. 271, 7593–7601.PubMedCrossRefGoogle Scholar
  3. 3.
    Madden, K. R. and Champoux, J. J. (1992) Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin. Cancer Res. 52, 525–532.PubMedGoogle Scholar
  4. 4.
    Bjornsti, M. A., Benedetti, P., Viglianti, G. A., and Wang, J. C. (1989) Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res. 49, 6318–6323.PubMedGoogle Scholar
  5. 5.
    D’Arpa, P., Machlin, P. S., Ratrie, H. D., Rothfield, N. F., Cleveland, D. W., and Earnshaw, W. C. (1988) cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc. Natl. Acad. Sci. USA 85, 2543–2547.PubMedCrossRefGoogle Scholar
  6. 6.
    Kikuchi, A. and Miyaike, M. (1993) Expression of human type I and II DNA topoisomerases and their derivatives in Escerichia coli, in Molecular Biology of DNA Topoisomerases and Its Application to Chemotherapy (Andoh, T., Ikeda, H., and Oguro, M., eds.), CRC, Boca Raton, FL, pp. 121–130.Google Scholar
  7. 7.
    Luckow, V. A. (1993) Baculovirus systems for the expression of human gene products. Curr. Opin. Biotechnol. 4, 564–572.PubMedCrossRefGoogle Scholar
  8. 8.
    Stewart, L., Ireton, G. C., and Champoux, J. J. (1996) The domain organization of human topoisomerase I. J. Biol. Chem. 271, 7602–7608.PubMedCrossRefGoogle Scholar
  9. 9.
    Stewart, L., Ireton, G. C., and Champoux, J. J. (1996) Reconstitution of human DNA topoisomerase I activity by fragment complementation. EMBO J. (Submitted.)Google Scholar
  10. 10.
    Zhelkovsky, A. M. and Moore, C. L. (1994) Overexpression of human DNA topoisomerase I in insect cells using a baculovirus vector. Protein Expr. Purif. 5, 364–370.PubMedCrossRefGoogle Scholar
  11. 11.
    Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254.PubMedCrossRefGoogle Scholar
  12. 12.
    Holden, J. A., Rolfson, D. H., and Low, R. L. (1990) DNA topoisomerase I from human placenta. Biochim. Biophys. Acta. 1049, 303–310.PubMedGoogle Scholar
  13. 13.
    Caron, P. R. and Wang, J. C. (1994) Alignment of primary sequences of DNA topoisomerases, in DNA Topoisomerases and Their Applications in Pharmacology Advances in Pharmacology (Liu, L. F., ed.), Academic, Boca Raton, FL, pp. 271–291.Google Scholar
  14. 14.
    Alsner, J., Svejstrup, J. Q., Kjeldsen, E., Sorensen, B. S., and Westergaard, O. (1992) Identification of an N-terminal domain of eukaryotic DNA topoisomerase I dispensable for catalytic activity but essential for in vivo function. J. Biol. Chem. 267, 12,408–12,411.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 1999

Authors and Affiliations

  • Lance Stewart
    • 1
  • James J. Champoux
    • 1
  1. 1.Department of MicrobiologyUniversity of WashingtonSeattle

Personalised recommendations